{"id":"intragamp","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Chills"},{"rate":null,"effect":"Infusion reactions"},{"rate":null,"effect":"Thrombosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an IVIG product, IntragamP contains polyvalent immunoglobulins (primarily IgG) derived from pooled human plasma. It works through multiple mechanisms including neutralization of pathogenic antibodies, blockade of Fc receptors on immune cells, and modulation of complement activation and cytokine production. This results in immunomodulatory and anti-inflammatory effects useful in treating primary immunodeficiencies and autoimmune conditions.","oneSentence":"IntragamP is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:34.647Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary immunodeficiency disorders"},{"name":"Autoimmune and inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT00405184","phase":"PHASE3","title":"Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)","status":"COMPLETED","sponsor":"CSL Limited","startDate":"2007-05","conditions":"Primary Immune Deficiency (PID)","enrollment":19}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IntragamP","genericName":"IntragamP","companyName":"CSL Limited","companyId":"csl-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IntragamP is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune responses. Used for Primary immunodeficiency disorders, Autoimmune and inflammatory conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}